Ortin Global Limited (NSE:ORTINGLOBE)
India · Delayed Price · Currency is INR 16.57
-0.88 (-5.04%)
At close: Aug 8, 2025, 3:30 PM IST
Paramount Global Revenue
In the fiscal year ending March 31, 2025, Ortin Global had annual revenue of 3.84M INR, down -81.84%. Ortin Global had revenue of 453.00K in the quarter ending March 31, 2025, a decrease of -68.72%.
Revenue
3.84M
Revenue Growth
-81.84%
P/S Ratio
30.24
Revenue / Employee
1.92M
Employees
2
Market Cap
115.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.84M | -17.28M | -81.84% |
| Mar 31, 2024 | 21.12M | -39.09M | -64.93% |
| Mar 31, 2023 | 60.20M | -22.11M | -26.86% |
| Mar 31, 2022 | 82.31M | 633.62K | 0.78% |
| Mar 31, 2021 | 81.67M | -1.89B | -95.86% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Divi's Laboratories | 96.52B |
| Cipla | 274.80B |
| Apollo Hospitals Enterprise | 225.51B |
| Mankind Pharma | 129.10B |
| Zydus Lifesciences | 236.08B |
| Fortis Healthcare | 80.94B |
| Alkem Laboratories | 133.04B |